Skip to content
thestock.space

As of 6 Nov 2026, Shree Ganesh Bio-Tech (India) is loss-making on a trailing 12-month basis, with a net loss of ₹0.52 Cr, so it has no P/E ratio. The share price is ₹0.43, 43% below its 52-week high. Sales fell 57% a year over 3 years. It is a small-cap company with a market cap of ₹17 Cr, ranked 68th of 72 Agricultural Inputs companies by market cap; the shares fell 41% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year
Open
₹0.42
Day high
₹0.44
Day low
₹0.42
Prev. close
₹0.43
Volume
4.3 L

Health check

1 fair · 5 to check
  • ReturnsBehind

    −41.1% over a year, better than 1 of 7 peers.

  • Price tagLoss-making

    Earnings were negative over the last 12 months.

  • GrowthShrinking

    Sales −57.0%, profit −43.0% a year over 3 years.

  • ProfitabilityWeak

    ROCE 0.8% vs peer median 20.9%.

  • Balance sheetFair

    Piotroski 4 of 9.

  • Red flags4 to check

    Loss-making over the last twelve months.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Agricultural Inputs

71 listed peers. Screen the industry

Small cap

₹17 Cr, #68 of 72 in its industry by size.

Moves with the market

Beta 0.89 vs the NIFTY 50: tracks the market closely.

Key metrics

Last 12 months to Jun 2026: sales ₹5 Cr · profit ₹−1 Cr
Market cap
₹17 Cr
Small cap
P/E
n/a
Industry 14.4
Price to book
0.27
Peers 4.28
Dividend yield
0.00%
ROE
0.6%
Peers 16.2%
ROCE
0.8%
Peers 20.9%
Debt to equity
n/a
Debt ₹0.00 Cr
EPS (TTM)
₹0.00
OPM (TTM)
−35.1%
Net margin −10.4%
Sales growth
+3.3%
Latest quarter vs a year ago
Profit growth
−275.3%
Latest quarter vs a year ago
Price to sales
3.42
EV/EBITDA −15.0

Strengths and risks

Risks to check

  • Loss-making over the last twelve months.
  • Return on equity is low at 0.6%.
  • Quarterly profit down 275.3% on a year ago.
  • 43% below its 52-week high.

No standout strengths in the headline numbers.

Derived automatically from reported figures. Not a recommendation.

About Shree Ganesh Bio-Tech (India)

Shree Ganesh Bio-Tech (India) Limited engages in plant tissue culture activities in India. The company engaged in trading seeds and bhushi. It also engages in production, processing, and marketing of hybrid seeds for various crops, including corn, sunflower, cotton, paddy, grain, and sorghum. The company was incorporated in 1982 and is based in Kolkata, India.

Headquarters
Kolkata
Employees
5
Sector
Basic Materials
ISIN
INE051N01026
Website
shreeganeshbiotech.info

Price range

52 weeks

₹0.40₹0.75

Today

₹0.42₹0.44
Avg volume (3M)
6.1 L
1-year return
minus 41.1%
From 52-week high
minus 42.7%

Peers · Agricultural Inputs

Capital-heavy industry columns

Compare with peersScreen the whole industry
Company
COROMANDELCoromandel International1,824.00minus 4.00%53,72434.517.020.9%9.4%0.1110.2%minus 12.4%
FACTFertilisers and Chemicals Travancore750.25minus 1.24%48,547–703.514.2%0.0%2.950.0%minus 15.3%
UPLUPL534.90plus 1.60%45,21423.96.09.9%20.0%0.83−1.2%minus 28.0%
PIINDPI Industries1,735.00minus 1.98%26,32130.013.114.7%24.2%0.031.1%minus 51.9%
SUMICHEMSumitomo Chemical India328.95plus 0.34%16,41929.421.021.0%20.3%0.02−2.6%minus 34.4%
CHAMBLFERTChambal Fertilizers & Chemicals384.70minus 0.91%15,4138.15.721.8%13.7%0.16−9.2%minus 19.4%
BAYERCROPBayer Cropscience3,316.30plus 0.48%14,90420.015.427.9%16.0%0.033.6%minus 31.7%
SHREEGANESShree Ganesh Bio-Tech (India)0.430.00%17––0.8%−35.1%–−57.0%minus 41.1%
Median of 7 peers–−0.91%26,32126.615.420.9%16.0%0.110.0%−28.0%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrJun 25Sep 25Dec 25Mar 26Jun 26
1.40.80.72.11.4
1.51.20.72.52.3
−0.1−0.4−0−0.4−0.9
−6.4%−51.6%−7.0%−20.0%−62.5%
0.40.40.40.30.3
–––0–
0.300.3−0.1−0.6
0.300.3−0.1−0.6
0.01–0.01–-0.01

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
−57.0%
Profit CAGR 3Y
−43.0%
EPS CAGR 3Y
−41.5%
ROE
0.6%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
62.520.3235
–minus 67.5%+13.2%minus 78.3%
60.320.523.15.6
2.1−0.2−0.1−0.6
3.4%−1.0%−0.5%−12.9%
0.31.11.41.5
0000
0.20−0.9−0.3
2.70.90.40.5
24.9%27.4%28.0%26.6%
20.60.30.4
–minus 69.6%minus 55.1%+35.6%
0.050.020.010.01

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
39.939.939.939.9
22.523.123.423.8
17.210.60.20.2
79.573.663.563.8
0000
––9.29.2
0.50.400
7973.254.354.6
79.573.663.563.8

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
10.510.2−10.2−8.2
−10.1−10.29.88.2
0.4−0.1−0.4−0
10.510.2−10.2−8.2

Shareholding pattern

This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.

Major shareholders

BSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you